Biotech

All Articles

Gain's phase 1 succeed paves way to prove Parkinson's drug's worth

.Increase Rehabs has set its own direct proving the effectiveness of its own Parkinson's condition t...

Actinogen records new period 2 records to save clinical depression medication

.Actinogen Medical's chances-- and inventory rate-- have rebounded slightly coming from earlier this...

Pfizer and Crown jewel add Quotient to multibillion-dollar equation

.Crown Jewel Pioneering and also Pfizer have added Quotient into their 10-program relationship, inki...

Bayer markers $547M contract to press limits of noncoding RNA

.Bayer execs were eager to worry to Fierce this summertime that the German pharma giant's appetite f...

UK introduces programs to launch 18 new scientific trial hubs

.Among a yearslong scientific trial decline in the U.K., a brand-new public-private partnership has ...

UPDATE: Genentech telegraphs 93 layoffs in California after sharing plans to shutter cancer immunology research device

.Adhering to the news of a huge layoff round in April and a significant restructuring initiative rev...

Neurocrine's KarXT rival attacks in phase 2-- but merely at low dose

.Neurocrine Biosciences has actually accomplished its own hoped-for profile in a stage 2 mental illn...

Vaderis' unusual blood vessel disorder drug lowers nosebleeds

.Vaderis Therapeutics' target to cultivate the very first medication aimed specifically at a particu...

Navigator brings up $100M to establish brand-new autoimmune pipeline

.Navigator Medicines has outfitted itself along with $100 thousand in set A funds as the younger bio...

Duality finds cash money for ADC tests as IPO wave infects Asia

.China's Duality Biotherapeutics has submitted (PDF) documents for a Hong Kong IPO, finding an undis...